NSW Showcase: TIA and MTPConnect | Recent Visits to Leading Australian Research Facilities
On May 30th, the NSW Research Infrastructure Showcase was hosted by TIA and MTPConnect. This event was dedicated to advancing therapeutic product development with the support of Australia’s state-of-the-art National Collaborative Research Infrastructure Strategy (NCRIS) facilities. This showcase provided detailed insights into available funding to support NCRIS access. Special guest Terry O’Riordan from AusIndustry presented […]
NCRIS Health welcomes the Australia RNA Blueprint
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint by the Australian Department of Industry, Science and Resources. The NCRIS Health Group includes Bioplatforms Australia, EMBL Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia. We are delighted that our advanced translational research infrastructure has been recognised […]
TIA launches new RNA Products Capability
On May 24, 2024, TIA launched of its groundbreaking RNA Products Capability at UNSW, with the assistance of NSW Senator Tim Ayres, Chief Scientist Cathy Foley and UNSW Vice Chancellor Atilla Brungs. This new capability is supported by funding from the National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Department of Education. It aims […]
UNSW RNA Institute
With the high-speed development of mRNA vaccines, brought on by rapid advances in the broader area of RNA biology and therapeutics, RNA products are being developed for a wide array of needs. From cancer treatments to diagnostics to agriculture, RNA science may hold the key to understanding some of the most complex scientific challenges. The […]
BASE mRNA Facility
mRNA vaccines and therapies provide a new strategy to treat disease. The BASE facility makes mRNA for scientific research. This facility has experience making hundreds of mRNAs vaccines and therapies. BASE offers end-to-end services, including the design, manufacture and LNP formulation of mRNA, and also provide off-the-shelf mRNAs. Read more about BASE here
